about
Pluripotent stem cells and gene therapyCardiac repair in a porcine model of acute myocardial infarction with human induced pluripotent stem cell-derived cardiovascular cellsEffective cardiac myocyte differentiation of human induced pluripotent stem cells requires VEGFThe RUNX1 +24 enhancer and P1 promoter identify a unique subpopulation of hematopoietic progenitor cells derived from human pluripotent stem cellsUtilizing chimeric antigen receptors to direct natural killer cell activityFunctional consequences of human induced pluripotent stem cell therapy: myocardial ATP turnover rate in the in vivo swine heart with postinfarction remodeling.Functional assessment of hematopoietic niche cells derived from human embryonic stem cells.Human embryonic stem cell-derived vascular progenitor cells capable of endothelial and smooth muscle cell functionApplication of a fracture risk algorithm to men treated with androgen deprivation therapy for prostate cancerTu-mor(e) blood cells from human pluripotent stem cells.Erythroid-specific expression of β-globin from Sleeping Beauty-transduced human hematopoietic progenitor cells.Targeting tumor-initiating cancer cells with dCD133KDEL shows impressive tumor reductions in a xenotransplant model of human head and neck cancerIdentification of an ADAM17 cleavage region in human CD16 (FcγRIII) and the engineering of a non-cleavable version of the receptor in NK cells.A fibrin patch-based enhanced delivery of human embryonic stem cell-derived vascular cell transplantation in a porcine model of postinfarction left ventricular remodelingPluripotent stem cell applications for regenerative medicineInduced Pluripotent Stem Cell-Derived Natural Killer Cells for Treatment of Ovarian Cancer.Angiogenic activity mediates bone repair from human pluripotent stem cell-derived osteogenic cellsBioenergetic and functional consequences of cellular therapy: activation of endogenous cardiovascular progenitor cellsGene Correction of iPSCs from a Wiskott-Aldrich Syndrome Patient Normalizes the Lymphoid Developmental and Functional Defects.Intraperitoneal delivery of human natural killer cells for treatment of ovarian cancer in a mouse xenograft model.Human embryonic stem cells differentiate into a homogeneous population of natural killer cells with potent in vivo antitumor activity.Identification of a KIR antisense lncRNA expressed by progenitor cells.Myeloablative hematopoietic cell transplantation for acute lymphoblastic leukemia: analysis of graft sources and long-term outcome.Toward clinical therapies using hematopoietic cells derived from human pluripotent stem cells.Use of human embryonic stem cells to understand hematopoiesis and hematopoietic stem cell niche.Pluripotent stem cell-derived natural killer cells for cancer therapy.Expression of chimeric receptor CD4ζ by natural killer cells derived from human pluripotent stem cells improves in vitro activity but does not enhance suppression of HIV infection in vivo.A synthetic substrate to support early mesodermal differentiation of human embryonic stem cells.Aryl hydrocarbon receptor inhibition promotes hematolymphoid development from human pluripotent stem cells.Use of RUNX2 expression to identify osteogenic progenitor cells derived from human embryonic stem cells.Silent IL2RG Gene Editing in Human Pluripotent Stem Cells.Clinical-scale derivation of natural killer cells from human pluripotent stem cells for cancer therapy.Development, expansion, and in vivo monitoring of human NK cells from human embryonic stem cells (hESCs) and and induced pluripotent stem cells (iPSCs)Fibrinogen Induces RUNX2 Activity and Osteogenic Development from Human Pluripotent Stem Cells.Human Pluripotent Stem Cells to Produce Cell-based Cancer Immunotherapy.Single Cell Resolution of Human Hematoendothelial Cells Defines Transcriptional Signatures of Hemogenic Endothelium.Mouse Xenograft Model for Intraperitoneal Administration of NK Cell Immunotherapy for Ovarian Cancer.Central nervous system acute lymphoblastic leukemia: role of natural killer cells.Efficient generation of endothelial cells from human pluripotent stem cells and characterization of their functional properties.Advances in the role of the aryl hydrocarbon receptor to regulate early hematopoietic development.
P50
Q26827643-8BAC092A-A87C-4943-A90F-9C492A4BC3ACQ27303668-E2718564-F767-478C-ACA4-7D66BB40FCCAQ27320840-893A79FD-9335-4376-9268-EE840867F570Q27329605-BF162DEE-36CE-4E14-9C5D-15E68BB5BE32Q28082868-51CA6AE0-4688-4C19-A479-69ACEAA74DCEQ30575719-01C98827-1909-4FC4-9373-E14E34F1BF2FQ33713843-D917F082-45FA-4CB2-91AC-BADA4E7B3039Q33726792-02D3D4F8-4083-4B3D-8DCD-C1CD3BB2267BQ33977543-B26A180E-973F-4E86-A6CF-B9065B16DF17Q34035688-BCCD4996-0388-4B63-B93A-FD30C3B3CF7AQ34117200-C03C141C-BFC7-4592-BA89-FC67C3F0BFF2Q35317540-9143254F-2BBE-472D-9672-93EC8A5A8A88Q35588890-58C3DF22-E1CC-42C5-8842-7AAEE35719ACQ36142907-45D49A14-86A0-428E-ADF8-D606BE804463Q36255019-CA9B93FE-F6B3-4153-AAE9-C807BDE1E90CQ36463830-F0F5A9AA-01CA-4A0A-B7CD-FF812AB5B471Q36691022-CD10A7C9-F3C2-4928-9A80-8F6ABF1D6EE2Q36793257-C49D94D2-94F5-4F33-A08C-C01CD79F2A91Q37171312-DF350E97-E731-409C-8D1A-AAC108AEDC32Q37178190-8083F752-27EB-4166-BC1F-4B102CC6B2FAQ37234607-261D30F6-C6AA-4D7A-A2B5-2EFA946D4CAFQ37255565-49A8BD43-7734-4EED-81BF-977620CE9C27Q37287039-55E91035-B519-407F-9ECE-2BC4DFBADFB5Q37398305-D01CD374-1446-400B-845F-BBF4CC2A5CD5Q37705452-7E41E61C-1B70-4DE5-B1D3-2BDDB3FA5839Q37783804-0AB9E919-1A11-416E-8D32-5149491CB030Q38365989-E5EFB439-7453-4C25-B3AD-39C497776E68Q38664569-ECB36E62-D374-4BA0-AF8F-8DBEA4632F60Q38702663-481CB1A2-AFE8-47B4-ABFC-9D56D25E8EC4Q38909903-5376045E-B52A-4BE2-ADCE-0EDBE9D2CDB2Q38919592-D90F985E-2EFF-4FB0-857C-796BC7F9A672Q39177978-BFB26ABA-9FF9-467B-AAC5-D12EA314C2D9Q41198652-04531B6B-BCE8-4ED6-9D64-C8619D6CB85FQ41927485-0E346A72-D3E9-44E4-86AE-A56C4E887B19Q46350666-1C699815-0D3D-45D2-9154-06B54B1E9B22Q46546508-914B05FF-6752-442C-899E-CE7FA3DD1D05Q46677873-C06EC800-F4DA-4970-A27F-3A060531B8D0Q50590535-03F1299D-FFAF-48A3-82E2-95F9DE26FE5EQ51664874-589E46E3-EC7A-45EA-8AA1-6C910A11B073Q52561737-3C058658-CFF8-4ED9-A348-24C7C9972264
P50
description
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Dan S Kaufman
@ast
Dan S Kaufman
@en
Dan S Kaufman
@es
Dan S Kaufman
@nl
Dan S Kaufman
@sl
type
label
Dan S Kaufman
@ast
Dan S Kaufman
@en
Dan S Kaufman
@es
Dan S Kaufman
@nl
Dan S Kaufman
@sl
prefLabel
Dan S Kaufman
@ast
Dan S Kaufman
@en
Dan S Kaufman
@es
Dan S Kaufman
@nl
Dan S Kaufman
@sl
P106
P31
P496
0000-0002-2003-2494